Literature DB >> 17084464

Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation.

M Niedrig1, K Sonnenberg, K Steinhagen, J T Paweska.   

Abstract

Two commercial assays for the detection of IgG antibody to West Nile virus (WNV), an indirect enzyme-linked immunosorbent assay (I-ELISA) and indirect fluorescent antibody test (IFAT), were evaluated against the virus neutralisation test. Excellent agreement with the virus neutralisation was obtained with both tests, i.e., 99.5% by I-ELISA and 100% by IFAT. The well-known serological cross-reactivity within the family of the Flaviviridae was analysed using sera with known antibodies against dengue virus, tick borne encephalitis virus and yellow fever virus. IgM and/or IgG positive sera were examined for reactivity by WNV-ELISA and WNV-IFAT. While cross-reactivity between 0 and 18.2% was recorded with IgM positive sera, there was extensive cross-reactivity of 15.7-100% with IgG positive sera.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084464     DOI: 10.1016/j.jviromet.2006.09.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  19 in total

Review 1.  West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety.

Authors:  Simonetta Pupella; Giulio Pisani; Karen Cristiano; Liviana Catalano; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-10-23       Impact factor: 3.443

Review 2.  West Nile Virus in Europe and Safety of Blood Transfusion.

Authors:  Giulio Pisani; Karen Cristiano; Simonetta Pupella; Giancarlo Maria Liumbruno
Journal:  Transfus Med Hemother       Date:  2016-05-10       Impact factor: 3.747

3.  Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

Authors:  S T Sonnleitner; J Simeoni; E Schmutzhard; M Niedrig; F Ploner; H Schennach; M P Dierich; G Walder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-10       Impact factor: 3.267

4.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

5.  First serological evidence of West Nile virus in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Janusz Paweska; Eric Leroy
Journal:  Virol J       Date:  2010-06-17       Impact factor: 4.099

6.  Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.

Authors:  Barbara W Johnson; Olga Kosoy; Elizabeth Hunsperger; Manuela Beltran; Mark Delorey; Farshad Guirakhoo; Thomas Monath
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

7.  West Nile Virus equine serosurvey in the Czech and Slovak republics.

Authors:  Zdenek Hubálek; Eva Ludvíková; Petr Jahn; František Treml; Ivo Rudolf; Petra Svobodová; Silvie Šikutová; Lenka Betášová; Jozef Bíreš; Miroslav Mojžíš; Martin Tinák; Martin Boldižár; Gabriela Citsoňová; Zuzana Staššíková
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-06       Impact factor: 2.133

8.  Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus.

Authors:  Matthias Niedrig; Oliver Kürsteiner; Christian Herzog; Karen Sonnenberg
Journal:  Clin Vaccine Immunol       Date:  2007-11-28

9.  Diagnostic potential and antigenic properties of recombinant tick-borne encephalitis virus subviral particles expressed in mammalian cells from Semliki Forest virus replicons.

Authors:  Lev Levanov; Suvi Kuivanen; Andrey Matveev; Sathyamangalam Swaminathan; Anu Jääskeläinen-Hakala; Olli Vapalahti
Journal:  J Clin Microbiol       Date:  2013-12-26       Impact factor: 5.948

10.  Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa.

Authors:  Marietjie Venter; Stacey Human; Dewald Zaayman; Gertruida H Gerdes; June Williams; Johan Steyl; Patricia A Leman; Janusz Tadeusz Paweska; Hildegard Setzkorn; Gavin Rous; Sue Murray; Rissa Parker; Cynthia Donnellan; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.